论文部分内容阅读
目的 观察肝癌切除免疫化疗对术后复发的影响。方法 121例病人分成4组:手术组(OP)、手术加化疗组(OP)手术加免疫治疗组(OI)、手术加免疫化疗组(OIC),化疗经肝动脉及门静脉途径;免疫治疗采用LAK细胞及白介素-Ⅱ。结果 4组3年复发率分别为76.7％、55.6％、45.2％、36.4％。OI组及OIC组术后复发率明显低于OP组。结论 术后免疫化疗有助于降低肝癌复发率。
Objective To observe the effect of resection and immunochemotherapy on recurrence after liver cancer. Methods 121 patients were divided into 4 groups: operation group (OP), operation and operation plus immunotherapy group (OI), operation plus immunochemistry and chemotherapy group (OIC), chemotherapy and hepatic artery and portal vein; immunotherapy LAK cells and interleukin-Ⅱ. Results The 3-year recurrence rates of 4 groups were 76.7%, 55.6%, 45.2% and 36.4% respectively. OI group and OIC group postoperative recurrence rate was significantly lower than the OP group. Conclusion Postoperative immunochemotherapy can help reduce the recurrence rate of liver cancer.